The P2X7 receptor: A key player in IL-1 processing and release

Journal of Immunology

Volumn 176, Issue 7, 2006, Pages 3877-3883

  Ferrari, Davide ^a   Pizzirani, Cinzia ^a   Adinolfi, Elena ^a   Lemoli, Roberto M ^b   Curti, Antonio ^b   Idzko, Marco ^c   Panther, Elisabeth ^c   Di Virgilio, Francesco ^a  

^a UNIVERSITY OF FERRARA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1; INTERLEUKIN 18; MEMBRANE RECEPTOR; PURINE P2X7 RECEPTOR; ADENOSINE TRIPHOSPHATE; INTERLEUKIN 1 RECEPTOR; LIGAND; PURINE P2 RECEPTOR;

ANTIGEN PRESENTATION; CELL MATURATION; CHRONIC INFLAMMATION; DRUG RECEPTOR BINDING; ENZYME ACTIVATION; HOST RESISTANCE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; MEDIATOR RELEASE; PRIORITY JOURNAL; PROTEIN FAMILY; SHORT SURVEY; SIGNAL TRANSDUCTION; TARGET CELL; ANIMAL; CLASSIFICATION; METABOLISM; REVIEW; SECRETION;

ADENOSINE TRIPHOSPHATE; ANIMALS; HUMANS; INTERLEUKIN-1; INTERLEUKIN-18; LIGANDS; RECEPTORS, INTERLEUKIN-1; RECEPTORS, PURINERGIC P2;

EID: 33646072818     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.176.7.3877     Document Type: Short Survey

References (94)

1. Dinarello, C. A. 1996. Biologic basis for interleukin-1 in disease. Blood 87: 2095-2147.
2. Dinarello, C. A. 2002. The IL-1 family and inflammatory diseases. Clin. Exp. Rheumatol. 20: S1-S13.
3. Reddy, P. 2004. Interleukin-18: recent advances. Curr. Opin. Hematol. 11: 405-410.
4. Arend, W. P., and C. Gabay. 2000, Physiologic role of interleukin-1 receptor antagonist. Arthritis Res. 2: 245-248.
5. Dinarello, C. A. 2000. The role of the inrerleukin-1-receptor antagonist in blocking inflammation mediated by interleukin-1. N. Engl. J. Med. 343: 732-734.
6. Dinarello, C. A. 2004. Unraveling the NALP-3/IL-1β inflammasome: a big lesson from a small mutation. Immunity 20: 243-244.
7. Gallucci, S., and P. Matzinger. 2001. Danger signals: SOS to the immune system. Curr. Opin. Immunol. 13: 114-119.
8. Di Virgilio, F. 2005. Purinergic mechanism in the immune system: a signal of danger for dendritic cells. Purinergic Signal. 1: 205-209.
9. Di Virgilio, F., P. Chiozzi, D. Ferrari, S. Falzoni, J. M. Sanz, A. Morelli, M. Torboli, G. Bolognesi, and O. R. Baricordi. 2001. Nucleotide receptors: an emerging family of regulatory molecules in blood cells. Blood 97: 587-600.
10. Ferrari, D., M. Villalba, P. Chiozzi, S. Falzoni, P. Ricciardi- Castagnoli, and F. Di Virgilio. 1996. Mouse microglial cells express a plasma membrane pore gated by extracellular ATP. J. Immunol. 156: 1531-1539.
11. Ferrari, D., P. Chiozzi, S. Falzoni, M. Dal Susino, L. Melchiorri, O. R. Baricordi, and F. Di Virgilio. 1997. Extracellular ATP triggers IL-1β release by activating the purinergic P2Z receptor of human macrophages. J. Immunol. 159: 1451-1458.
12. 7 receptors. J. Biol. Chem. 276: 125-132.
13. Allan, S. M., P. J. Tyrrell, and N. J. Rothwell. 2005. Interleukin-1 and neuronal Injury. Nat. Rev. Immunol. 5: 629-640.
14. Tanaka, Y., S. Nakayamada, and Y. Okada. 2005, Osteoblasts and osteoclasts in bone remodeling and inflammation. Curr. Drug Targets. Inflamm. Allergy 4: 325-328.
15. Hazuda, D. J., J. Strickler, F. Kueppers, P. L. Simon, and P. R. Young. 1990. Processing of precursor interleukin 1β and inflammatory disease. J. Biol. Chem. 265: 6318-6322.
16. Thornberry, N. A., H. G. Bull, J. R. Calaycay, K. T. Chapman, A. D. Howard, M. J. Kostura, D. K. Miller, S. M. Molineaux, J. R. Weidner, J. Aunins, et al. 1992. A novel heterodimeric cysteine protease is required for interleukin-1β processing in monocytes. Nature 356: 768-774.
17. Schmitz, J., A. Owyang, E. Oldham, Y. Song, E. Murphy, T. K. McClanahan, G. Zurawski, M. Moshrefi, J. Qin, X. Li, et al. 2005. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 23: 479-490.
18. Martinon, F., K. Burns, and J. Tschopp. 2002. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of pro-IL-β. Mol. Cell 10: 417-426.
19. Martinon, F., and J. Tschopp. 2004. Inflammatory caspases: linking an intracellular innate immune system to autoinflammatory diseases. Cell 117: 561-574.
20. Greenfeder, S. A., P. Nunes, L. Kwee, M. Labow, R. A. Chizzonite, and G. Ju. 1995. Molecular cloning and characterization of a second subunit of the interleukin 1 receptor complex. J. Biol. Chem. 270: 13757-13765.
21. Colotta, F., F. Re, M. Muzio, R. Bertini, N. Polentarutti, M. Sironi, J. G. Giri, S. K. Dower, J. E. Sims, and A. Mantovani. 1993. Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4. Science 261: 472-475.
22. Dinarello, C. A. 2000. The role of the interleukin-1 receptor antagonist in blocking inflammation mediated by interleukin-1. N. Engl. J. Med. 343: 732-734.
23. Dinarello, C. A. 1994. The interleukin-1 family: 10 years of discovery. FASEB J. 8: 1314-1325.
24. Nicklin, M. J. H., D. E. Hughes, J. L. Barton, J. M. Ure, and G. W. Duff. 2000. Arterial inflammation in mice lacking the interleukin 1 receptor antagonist gene. J. Exp. Med. 191: 303-312.
25. Horai, R., S. Saijo, H. Tanioka, S. Nakae, K. Sudo, A. Okahara, T. Ikuse, M. Asano, and Y. Iwakura. 2000. Development of chronic inflammatory atthropathy resembling rheumatoid arthritis in interleukin 1 receptor antagonist-deficient mice. J. Exp. Med. 191: 313-320.
26. Bresnihan, B., J. M. varo-Gracia, M. Cobby, M. Doherty, Z. Domljan, P. Emery, G. Nuki, K. Pavelka, R. Rau, B. Rozman, et al. 1998. Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist. Arthritis Rheum. 41: 2196-2204.
27. Furst, D. E. 2004. Anakinra: review of recombinant human interleukin-1 receptor antagonist in the treatment of rheumatoid arthritis. Clin. Ther. 26: 1960-1975.
28. Ghayur, T., S. Banerjee, M. Hugunin, D. Butler, L. Herzog, A. Carter, L. Quintal, L. Sekut, R. Talanian, M. Paskind, et al. 1997. Caspase-1 processes IFN-γ-inducing factor and regulates LPS-induced IFN-γ production. Nature 386: 619-623.
29. Gu, Y., K. Kuida, H. Tsutsui, G. Ku, K. Hsiao, M. A. Fleming, N. Hayashi, K. Higashino, H. Okamura, K. Nakanishi, et al. 1997. Activation of interferon γ inducing factor mediated by interleukin-1β converting enzyme. Science 275: 206-209.
30. McInnes, I. B., J. A. Gracie, B. P. Leung, X. Q. Wei, and F. Y. Liew. 2000. Interleukin 18: a pleiotropic participant in chronic inflammation. Immunol. Today 21: 312-315.
31. Ralevic, V., and G. Burnstock. 1998. Receptors for purines and pyrimidines. Pharmacol. Rev. 50: 413-492.
32. Burnstock, G., and G. E. Knight. 2004. Cellular distribution and functions of P2 receptor subtypes in different systems. Int. Rev. Cytol. 240: 31-304.
33. Di Virgilio, F. 1995. The P2Z purinoceptor: an intriguing role in immunity, inflammation and cell death. Immunol. Today 16: 524-528.
34. 7). Science 272: 735-738.
35. 7 receptor impairs ATP-induced IL-1β release from human monocytes. J. Immunol. 172: 3399-3405.
36. 7 receptor. Receptors Channels 5: 347-354.
37. Freist, W., J. F. Verhey, W. Stuhmer, and D. H. Gauss. 1998. ATP binding site of P2X channel proteins: structural similarities with class II aminoacyl-tRNA synthetases. FEBS Lett. 434: 61-65.
38. 7 receptor. J. Biol. Chem. 279: 31287-31295.
39. 7 contains multiple protein- and lipid-interaction motifs including a potential binding site for bacterial lipopolysaccharide. J. Immunol. 167: 1871-1876.
40. Egan, T. M., J. A. Cox, and M. M. Voigt. 2004. Molecular structure of P2X receptors. Curr. Top. Med. Chem. 4: 821-829.
41. 7 receptor. J. Biol. Chem. 276: 11135-11142.
42. 7 receptor. J. Biol. Chem. 278: 17108-17113.
43. 7 function and impairs ATP-induced mycobacterial killing by macrophages. J. Biol. Chem. 281: 2079-2086.
44. 7 receptor of human leukemic lymphocytes. J. Immunol. 175: 82-89.
45. 7 gene in 1-2% of the Caucasian population. FEBS Lett. 579: 2675-2678.
46. 7 gene with tuberculosis in a Gambian population. J. Infect. Dis. 186: 1458-1462.
47. Di Virgilio, F., O. R. Baricordi, R. Romagnoli, and P. G. Baraldi. 2005. Leukocyte P2 receptors: a novel target for anti-inflammatory and anti-tumor therapy. Curr. Drug Targets Cardiovasc. Haematol. Disord. 5: 85-99.
48. 7 purinergic receptor stimulation activate a common cytolytic pore. Am. J. Physiol. 277(4 Pt. 1): C766-C776.
49. Verhoef, P. A., S. B. Kertesy, M. Estacion, W. P. Schilling, and G. R. Dubyak. 2004. Maitotoxin induces biphasic interleukin-1β secretion and membrane blebbing in murine macrophages. Mol. Pharmacol. 66: 909-920.
50. Ellioit, J. I., A. Surprenant, F. M. Marelli-Berg, J. C. Cooper, R. L. Cassady-Cain, C. Wooding, K. Linton, D. R. Alexander, and C. F. Higgins. 2005. Membrane phosphatidylserine distribution as a non-apoptotic signalling mechanism in lymphocytes. Nat. Cell Biol. 7: 808-816.
51. Steinberg, T. H., and S. C. Silverstein. 1987. Extracellular ATP4- promotes cation fluxes in the J774 mouse macrophage cell line. J. Biol. Chem. 262: 3118-3122.
52. Di Virgilio, F., P. Chiozzi, S. Falzoni, D. Ferrari, J. M. Sanz, V. Venketaraman, and O. R. Baricordi. 1998. Cytolytic P2X purinoceptors. Cell Death Differ. 5: 191-199.
53. Hogquist, K. A., E. R. Unanue, and D. D. Chaplin. 1991. Release of IL-1 from mononuclear phagocytes. J. Immunol. 147: 2181-2186.
54. Perregaux, D., and C. A. Gabel. 1994. Interleukin-1β maturation and release in response to ATP and nigericin: evidence that potassium depletion mediated by these agents is a necessary and common feature of their activity. J. Biol. Chem. 269: 15195-15203.
55. Griffiths, R. J., E. J. Sram, J. T. Downs, and I. G. Otterness. 1995. ATP induces the release of IL-1 from LPS-primed cells in vivo. J. Immunol. 154: 2821-2828.
56. Di Virgilio, F., D. Ferrari, S. Falzoni, P. Chiozzi, M. Munerati, T. H. Steinberg, and O. R. Baricordi. 1996. P2 purinoceptors in the immune system. Ciba Found. Symp. 198: 290-302.
57. 7 receptor alters leukocyte function and attenuates an inflammatory response. J. Immunol. 168: 6436-6445.
58. 7 purinoceptor gene abolishes chronic inflammatory and neuropathic pain. Pain 114: 386-396.
59. Perregaux, D., J. Barberia, A. J. Lanzetti, K. F. Geoghegan, T. J. Catty, and C. A. Gabel. 1992. IL-1β maturation: evidence that mature cytokine formation can be induced specifically by nigericin. J. Immunol. 149: 1294-1303.
60. Laliberte, R. E., J. Eggler, and C. A. Gabel. 1999. ATP treatment of human monocytes promotes caspase-1 maturation and externalization. J. Biol. Chem. 274: 36944-36951.
61. Sanz, J. M., and F. Di Virgilio. 2000. Kinetics and mechanism of ATP-dependent IL-1β release from microglial cells. J. Immunol. 164: 4893-4898.
62. Mariathasan, S., K. Newton, D. M. Monack, D. Vucic, D. M. French, W. P. Lee, M. Roose-Girma, S. Erickson, and V. M. Dixit. 2004, Differential activation of the inflammasome by caspase-I adaptors ASC and Ipaf. Nature 430: 213-218.
63. 7 receptor is dependent on TLR signals and requires NF-κB-driven protein synthesis. J. Immunol. 175: 7611-7622.
64. Mehta, V. B., J. Hart, and M. D. Wewers. 2001. ATP-stimulated release of interleukin (IL)-1β and IL-18 requires priming by lipopolysaccharide and is independent of caspase-1 cleavage. J. Biol. Chem. 276: 3820-3826.
65. + release. Am. J. Physiol. 286: C1100-C1108.
66. Andrei, C., P. Margiocco, A. Poggi, L. V. Lotti, M. R. Torrisi, and A. Rubartelli. 2004. Phospholipases C and A2 control lysosome-media ted IL-1β secretion: implications for inflammatory processes. Proc. Natl. Acad. Sci. USA 101: 9745-9750.
67. Murgia, M., P. Pizzo, T. H. Steinberg, and V. F. Di Virgilio. 1992. Characterization of the cytotoxic effect of extracellular ATP in J774 mouse macrophages. Biochem. J. 288: 897-901.
68. Denlinger, L. C., G. Angelini, K. Schell, D. N. Green, A. G. Guadarrama, U. Prabhu, D. B. Coursin, P. J. Bertics, and K. Hogan. 2005. Detection of human P2X7 nucleotide receptor polymorphisms by a novel monocyte pore assay predictive of alterations in lipopolysaccharide-induced cytokine production. J. Immunol. 174: 4424-4431.
69. 7 nucleotide receptor in monocytes, macrophages, and HEK-293 cells. Am. J. Physiol. 285: C286-C299.
70. Cheneval, D., P. Ramage, T. Kastelic, T. Szelestenyi, H. Niggli, R. Hemmig, M. Bachmann, and A. MacKenzie. 1998. Increased mature interleukin-1β (IL-1β) secretion from THP-1 cells induced by nigericin is a result of activation of p45 IL-1β-converting enzyme processing. J. Biol. Chem. 273: 17846-17851.
71. MacKenzie, A., H. L. Wilson, E. Kiss-Toth, S. K. Dower, R. A. North, and A. Surprenant. 2001. Rapid secretion of interleukin-1β by microvesicle shedding. Immunity 15: 825-835.
72. Morel, O., F. Toti, B. Hugel, and J. M. Freyssinet. 2004. Cellular microparticles: a disseminated storage pool of bioactive vascular effectors. Curr. Opin. Hematol. 11: 156-164.
73. Morelli, A., P. Chiozzi, A. Chiesa, D. Ferrari, J. M. Sanz, S. Falzoni, P. Pinton, R. Rizzuto, M. F. Olson, and F. Di Virgilio. 2003. Extracellular ATP causes ROCK I-dependent bleb formation in P2X7-transfected HEK293 cells. Mol. Biol. Cell 14: 2655-2664.
74. Bianco, F., E. Pravettoni, A. Colombo, U. Schenk, T. Moller, M. Marteoli, and C. Verderio. 2005. Astrocyte-derived ATP induces vesicle shedding and IL-1β release from microglia. J. Immunol. 174: 7268-7277.
75. Pellegatti, P., S. Falzoni, P. Pinton, R. Rizzuto, and F. Di Virgilio. 2005. A novel recombinant plasma membrane-targeted luciferase reveals a new pathway for ATP secretion. Mol. Biol. Cell 16: 3659-3665.
76. Ferrari, D., P. Chiozzi, S. Falzoni, S. Hanau, and F. Di Virgilio. 1997. Purinergic modulation of interleukin-1β release from microglial cells stimulated with bacterial endotoxin. J. Exp. Med. 185: 579-582.
77. 7 receptor channels. J. Neurosci. 22: 3061-3069.
78. Koshlukova, S. E., T. L. Lloyd, M. W. Araujo, and M. Edgerton. 1999. Salivary histatin 5 induces non-lytic release of ATP from Candida albicans leading to cell death. J. Biol. Chem. 274: 18872-18879.
79. Bodin, P., and G. Burnstock. 2001. Purinergic signalling: ATP release. Neurochem. Res. 26: 959-969.
80. 7 receptor activator, the human cathelicidin-derived peptide LL37, induces IL-1β processing and release. J. Immunol. 172: 4987-4994.
81. Crane, J. K., T. M. Naeher, S. S. Choudhari, and E. M. Giroux. 2005. Two pathways for ATP release from host cells in enteropathogenic Escherichia coli infection. Am. J. Physiol. 289: G407-G417.
82. Beigi, R., E. Kobatake, M. Aizawa, and G. R. Dubyak. 1999. Detection of local ATP release from activated platelets using cell surface-attached firefly luciferase. Am. J. Physiol. 276: C207-C278.
83. 7 nucleotide receptor expression by pro- and anti-inflammatory stimuli in THP-1 monocytes. J. Leukocyte Biol. 64: 265-273.
84. 7 receptor expression and function in human astrocytes. Glia 49: 245-258.
85. Falzoni, S., M. Munerati, D. Ferrati, S. Spisani, S. Moretti, and F. Di Virgilio. 1995. The purinetgic P2Z receptor of human macrophage cells: characterization and possible physiological role. J. Clin. Invest. 95: 1207-1216.
86. Detks, R., and K. Beaman. 2004. Regeneration and tolerance factor modulates the effect of adenosine triphosphate-induced interleukin 1β secretion in human macrophages. Hum. Immunol. 65: 676-682.
87. 7 purinoceptor. Immunity 19: 571-582.
88. Perregaux, D. G., and C. A. Gabel. 1998. Post-translational processing of murine IL-1: evidence that ATP-induced release of IL-1α and IL-1β occurs via a similar mechanism. J. Immunol. 160: 2469-2477.
89. 7 receptor activation. J. Immunol. 173: 1202-1208.
90. 7 receptor polymorphism impairs extracellular adenosine 5′-triphosphate- induced interleukin-18 release from human monocytes. Genes Immun. 5: 588-591.
91. 2+ and membrane potential and promotes transcription of IL-6 in macrophages. Proc. Natl. Acad. Sci. USA 101: 9479-9484.
92. la Sala, A., D. Ferrari, F. Di Virgilio, M. Idzko, J. Notgauet, and G. Girolomoni. 2003. Alerting and tuning the immune response by extracellular nucleotides. J. Leukocyte Biol. 73: 339-343.
93. Nathan, C. 2002. Points of control in inflammation. Nature 420: 846-852.
94. 7 ATP channel. Biochem. Biophys. Res. Commun. 332: 17-27.